These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28569194)

  • 41. Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.
    Soliman NA; Nabhan MM; Abdelrahman SM; Abdelaziz H; Helmy R; Ghanim K; Bazaraa HM; Badr AM; Tolba OA; Kotb MA; Eweeda KM; Fayez A
    Nephrol Ther; 2017 May; 13(3):176-182. PubMed ID: 28161266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic analysis--a diagnostic tool for primary hyperoxaluria type I.
    Milosevic D; Rinat C; Batinic D; Frishberg Y
    Pediatr Nephrol; 2002 Nov; 17(11):896-8. PubMed ID: 12432429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.
    Nagara M; Tiar A; Ben Halim N; Ben Rhouma F; Messaoud O; Bouyacoub Y; Kefi R; Hassayoun S; Zouari N; Ben Ammar MS; Abdelhak S; Chemli J
    Gene; 2013 Sep; 527(1):316-20. PubMed ID: 23810941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ENDOCRINE MANIFESTATIONS OF PRIMARY HYPEROXALURIA.
    Murad S; Eisenberg Y
    Endocr Pract; 2017 Dec; 23(12):1414-1424. PubMed ID: 29144803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical and genetic diagnosis of the primary hyperoxalurias: a review.
    Rumsby G
    Mol Urol; 2000; 4(4):349-54. PubMed ID: 11156702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Primary hyperoxaluria].
    Cochat P; Fargue S; Bacchetta J; Bertholet-Thomas A; Sabot JF; Harambat J
    Nephrol Ther; 2011 Jul; 7(4):249-59. PubMed ID: 21636340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.
    Cochat P; Hulton SA; Acquaviva C; Danpure CJ; Daudon M; De Marchi M; Fargue S; Groothoff J; Harambat J; Hoppe B; Jamieson NV; Kemper MJ; Mandrile G; Marangella M; Picca S; Rumsby G; Salido E; Straub M; van Woerden CS;
    Nephrol Dial Transplant; 2012 May; 27(5):1729-36. PubMed ID: 22547750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.
    Fang X; He L; Xu G; Lin H; Xu M; Geng H
    Pediatr Nephrol; 2019 Oct; 34(10):1785-1790. PubMed ID: 31123811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
    Monico CG; Rossetti S; Belostotsky R; Cogal AG; Herges RM; Seide BM; Olson JB; Bergstrahl EJ; Williams HJ; Haley WE; Frishberg Y; Milliner DS
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2289-95. PubMed ID: 21896830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria.
    Clifford-Mobley O; Hewitt L; Rumsby G
    Ann Clin Biochem; 2016 Jul; 53(Pt 4):485-94. PubMed ID: 26342005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary hyperoxaluria in a compound heterozygote infant.
    Mayordomo-Colunga J; Riverol D; Salido E; Santos F
    World J Pediatr; 2011 May; 7(2):173-5. PubMed ID: 20549407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Next-generation sequencing in identification of pathogenic variants in primary hyperoxaluria among 21 Egyptian families: Identification of two novel AGXT gene mutations.
    Ahmed HA; Fadel FI; Abdel Mawla MA; Salah DM; Fathallah MG; Amr K
    Mol Genet Genomic Med; 2022 Aug; 10(8):e1992. PubMed ID: 35661454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The primary hyperoxalurias.
    Hoppe B; Beck BB; Milliner DS
    Kidney Int; 2009 Jun; 75(12):1264-1271. PubMed ID: 19225556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. D-glyceric aciduria is caused by genetic deficiency of D-glycerate kinase (GLYCTK).
    Sass JO; Fischer K; Wang R; Christensen E; Scholl-Bürgi S; Chang R; Kapelari K; Walter M
    Hum Mutat; 2010 Dec; 31(12):1280-5. PubMed ID: 20949620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New insights into the mechanism of substrates trafficking in Glyoxylate/Hydroxypyruvate reductases.
    Lassalle L; Engilberge S; Madern D; Vauclare P; Franzetti B; Girard E
    Sci Rep; 2016 Feb; 6():20629. PubMed ID: 26865263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue differences in the expression of mutations and polymorphisms in the GRHPR gene and implications for diagnosis of primary hyperoxaluria type 2.
    Bhat S; Williams EL; Rumsby G
    Clin Chem; 2005 Dec; 51(12):2423-5. PubMed ID: 16306119
    [No Abstract]   [Full Text] [Related]  

  • 57. Folding Defects Leading to Primary Hyperoxaluria.
    Oppici E; Dindo M; Conter C; Borri Voltattorni C; Cellini B
    Handb Exp Pharmacol; 2018; 245():313-343. PubMed ID: 29071511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extraction of glyceric and glycolic acids from urine with tetrahydrofuran: utility in detection of primary hyperoxaluria.
    Dietzen DJ; Wilhite TR; Kenagy DN; Milliner DS; Smith CH; Landt M
    Clin Chem; 1997 Aug; 43(8 Pt 1):1315-20. PubMed ID: 9267307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations in HAO1 encoding glycolate oxidase cause isolated glycolic aciduria.
    Frishberg Y; Zeharia A; Lyakhovetsky R; Bargal R; Belostotsky R
    J Med Genet; 2014 Aug; 51(8):526-9. PubMed ID: 24996905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperoxaluria and urolithiasis in young children: an atypical presentation.
    Monico CG; Milliner DS
    J Endourol; 1999 Nov; 13(9):633-6. PubMed ID: 10608514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.